What is it about?
Encompassing recent randomized controlled trials, clinical trials, and meta-analyses, as well as the comparison of the latest authoritative guidelines including the NCCN, ASCO, and ITAC guidelines in this field, the objective of this review is to present current overview and recommendations for the treatment of cancer-associated VTE.
Featured Image
Why is it important?
It can help clinicians to better understand the up-to-date status in treatment of cancer-associated VTE.
Perspectives
I hope this review can provide clinicians the picture of up-to-date status in treatment of cancer-associated VTE.
Dr Wei Xiong
Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Read the Original
This page is a summary of: Current status of treatment of cancer-associated venous thromboembolism, Thrombosis Journal, March 2021, Springer Science + Business Media,
DOI: 10.1186/s12959-021-00274-x.
You can read the full text:
Contributors
The following have contributed to this page
